Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 52.20
+0.90 (1.75%)
Apr 2, 2025, 1:30 PM CST
Pharmosa Biopharm Revenue
In the year 2024, Pharmosa Biopharm had annual revenue of 167.57M TWD, down -46.72%. Pharmosa Biopharm had revenue of 117.05M in the quarter ending December 31, 2024.
Revenue
167.57M
Revenue Growth
-46.72%
P/S Ratio
39.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.74B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Polaris Group | 107.00M |